CLINICAL_TRIALS
trial_result
· 2011-12-13
Clinical Trial Update: Evaluation of 2 Doses of Intravenous Droperidol in the Prevention of Postoperative Nausea [Phase 4]
Summary
Phase 4 trial evaluating two intravenous doses of droperidol to prevent postoperative nausea and vomiting has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University Hospital, Bordeaux | Conditions: Nausea, Vomiting | Phase 4 | Status: TERMINATED